I am a research fellow in health economics at the Manchester Centre for Health Economics, School of Health Sciences, Faculty of Biology, Medicine and Health. My research uses economic analyses to inform decision-making for health technology assessment and health policy. Currently, I lead the economics programme for the Innovate Manchester Advanced Therapy Centre Hub (iMATCH) to support using advanced cell and gene therapies at scale in the health care system. Previously, I delivered the health economics programme for the Medical Research Council’s Precision Medicine Consortium MASTERPLANS – a collaboration between academic, industry, and patient partners - to develop effective and cost-effective ways to stratify treatments for systemic lupus erythematosus. I co-lead the postgraduate ‘Economics of Genomics and Precision Medicine’ module [BIOL67372] with Dr. Alexander Thompson where I teach decision-analytic modelling in the context of diagnostic tests and precision medicine. I also support student research projects at all levels and regularly supervise health economics research by PhD, masters, and medical students. I lead the external research seminar programme at the Manchester Centre for Health Economics.

Research Interests

• Cost-effectiveness analysis of health technologies
  
• Economics of precision medicine
• Early economic evaluation of health technologies
  
  

Memberships of Committees and Professional Bodies

• Member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
• Member of the International Health Economics Association (iHEA)
• Member of the European Health Economics Association (EuHEA)
• Member of the UK Health Economists' Study Group (HESG)
• President of the ISPOR Student Chapter at The University of Manchester, 2015-17
  
  

Teaching and Supervision

Doctoral Research Supervision

• PhD Co-supervisor - Leonie Penner (2017-2021)
  Doctoral Thesis: What is the Economic Impact of Hazardous Prescribing of Anticoagulants and Does a Pharmacist-led Information Technology Intervention Reduce this Impact?
  With: Prof. Rachel Elliott, Prof. Niels Peek, Prof. Darren Ashcroft
  

• PhD Co-supervisor - Yubo Wang (2018-Present)
  Doctoral Thesis: Evaluation of the Clinical and Cost-effectiveness of Long-term Treatments for Women with Breast Cancer
  With: Dr. Li-Chia Chen, Dr. Douglas Steinke

• PhD Co-supervisor - Anna Donten (2019-2022)
  Doctoral Thesis: The Economic Impact of Precision Medicine in Rheumatology: Targeting the use of Methotrexate in Early Rheumatoid Arthritis
  With: Prof. Katherine Payne, Dr. Suzanne Verstappen
  

Postgraduate Research Supervision

• Postgraduate Dissertation Supervisor - MSc Economics, The University of Manchester (2020)
  
• Postgraduate Dissertation Supervisor - MSc Health Economics, The University of York (2017)
• Postgraduate Dissertation Supervisor - MRes Translational Medicine, The University of Manchester (2016-17)
• Postgraduate Academic Advisor - Masters of Research Programme in the Faculty of Biology, Medicine and Health (2016-17)
  

Undergraduate Research Supervision

• Year 3 Applied Personal Excellence Pathway Supervisor - MBChB Medicine, The University of Manchester (2022)
• Year 2 Personal Excellence Pathway Supervisor - MBChB Medicine, The University of Manchester (2018)
• Undergraduate Dissertation Supervisor - BSc Management and Innovation in Healthcare, The University of Manchester (2018)

Taught Academic Modules

• Module Co-lead - Economics of Genomics and Precision Medicine (MEDN67372), MSc Genomic Medicine & CPD Workshop (2016-22)
• Teaching Assistant - Health Economics (MEDN60092), MPH Public Health (2014-15)
• Teaching Assistant - An Introduction to Population Health - Coursera MOOC (2015)
  
  

Qualifications

• Doctor of Philosophy (Doctoral Thesis: An Economic Evaluation of a Biomarker Test to Stratify Treatment for Rheumatoid Arthritis)
• MSc Health Economics (Distinction)
• MSc Economics (Distinction)
• BA (Hons) Economics for Business (First Class)
• Fellow of the Higher Education Academy
  
  

Contact Details

• Prof. Katherine Payne, Professor of Health Economics, The University of Manchester
• Prof. Anne Barton, Professor of Rheumatology, The University of Manchester
• Prof. Ian Bruce, Professor of Rheumatology, The University of Manchester